share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

辉瑞 | 4:持股变动声明-董事 NARAYEN SHANTANU
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心信息
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on June 28, 2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Narayen is located at 66 Hudson Boulevard East, New York, NY. Without further details on the transaction, investors are advised to seek additional information to understand the potential impact on their investment decisions regarding Pfizer stock.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on June 28, 2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Narayen is located at 66 Hudson Boulevard East, New York, NY. Without further details on the transaction, investors are advised to seek additional information to understand the potential impact on their investment decisions regarding Pfizer stock.
辉瑞公司[PFE]的报告人Shantanu Narayen于2024年6月28日参与了一次交易,交易的具体细节,如操作类型、状态币、涉及股数、股份性质、交易价格和参股金融后的持股情况,在公告中未披露。Narayen提供的地址位于纽约州纽约市东66街哈德逊大道66号。在交易的更多细节未披露的情况下,建议投资者寻求更多信息,以了解辉瑞股票的潜在影响,并做出投资决策。
辉瑞公司[PFE]的报告人Shantanu Narayen于2024年6月28日参与了一次交易,交易的具体细节,如操作类型、状态币、涉及股数、股份性质、交易价格和参股金融后的持股情况,在公告中未披露。Narayen提供的地址位于纽约州纽约市东66街哈德逊大道66号。在交易的更多细节未披露的情况下,建议投资者寻求更多信息,以了解辉瑞股票的潜在影响,并做出投资决策。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息